(MENAFN- GlobeNewsWire - Nasdaq) Boost ROI by targeting mitral, tricuspid and LAA closure innovations, expanding clinical indications, and pursuing startup acquisitions and imaging partnerships.

NEW YORK CITY -- A transcatheter aortic valve replacement (TAVR) system could work as a last resort for patients with left ventricular assist device (LVAD)-associated aortic regurgitation (AR), ...

Haemonetics is shaking up the large-bore closure space market with the acquisition of Vivasure Medical, the developer of the PerQseal Elite. The acquisition includes an upfront cash payment of $116 ...

Haemonetics has announced US Food and Drug Administration (FDA) approval of the PerQseal Elite vascular closure system for large-bore arterial procedures. According to the company, the approval ...

NEW ORLEANS — The first embolic protection device designed to prevent periprocedural debris from entering any of the three cerebral vessels or the descending aorta during transcatheter aortic valve ...

LONDON, March 4, 2026 /PRNewswire/ -- The "Structural Heart Devices Market – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032" report has been added to the Credence Research Inc.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE)-- "Structural Heart Devices Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ...